440
M. Zarei and A. Jarrahpour
Vol 50
4.91 (H-3, d, 1H, J = 8.6 Hz), 6.71–8.12 (ArH, m, 13H); 13C
NMR (62.9 MHz, CDCl3) d 55.3 (OMe), 55.9 (C-3), 56.5
(C-4), 116.3, 117.8, 119.0, 123.9, 125.0, 128.5, 129.2, 129.9,
135.7, 141.4, 143.8, 154.6 (aromatic carbons). Anal. Calcd for
C21H18N2O5S: C, 61.45; H, 4.42; N, 6.83. Found: C, 61.53; H,
4.55; N, 6.88.
Table 2
Synthesis of b-sultams 9a–k by reagent 6.
Isolated yield
(%)
Entry
R1
R2
R3
Product
1
2
3
4
5
6
7
8
4-MeOC6H4 4-NO2C6H4
4-MeOC6H4 4-NO2C6H4
Ph
Me
Ph
Me
Ph
Me
Ph
Ph
Ph
Ph
Ph
9a
9b
9c
9d
9e
9f
9g
9h
9i
93
67
88
65
92
72
86
88
85
84
90
4-Methyl-2-(p-methoxyphenyl)-3-(p-nitrophenyl)-1,2-thiazetidine-
1,1-dioxide (9b). White solid; mp: 138–140ꢁC. IR (KBr) cmꢀ1
:
c-C6H11
c-C6H11
c-C6H11
c-C6H11
Me
4-MeC6H4
4-MeC6H4
4-ClC6H4
4-ClC6H4
4-NO2C6H4
Ph
4-MeOC6H4
4-NO2C6H4
Ph
1133, 1318 (SO2), 1332, 1528 (NO2). 1H NMR (250 MHz,
CDCl3) d 1.14 (Me, d, 3H, J = 7.1 Hz), 3.66 (OMe, s, 3H), 4.45
(H-4, dq, 1H, J = 7.1, 8.8 Hz), 4.84 (H-3, d, 1H, J = 8.8 Hz), 6.84–
3
8.07 (ArH, m, 8H); C NMR (62.9MHz, CDCl3) d 12.7 (Me),
Me
Me
Me
55.5 (OMe), 55.8 (C-4), 56.2 (C-3), 117.1, 118.5, 122.4, 123.9,
126.2, 128.5, 140.8, 152.4 (aromatic carbons). Anal. Calcd for
C16H16N2O5S: C, 55.16; H, 4.63; N, 8.04. Found: C, 55.26; H,
4.76; N, 7.97.
9
10
11
9j
9k
PhCH2
Acknowledgment. The authors thank the Shiraz University
Research Council for the financial support (Grant no. 90-GR-SC-23).
EXPERIMENTAL
All needed chemicals were purchased from Merck, Fluka, and
Acros chemical companies. IR spectra were run on a Shimadzu
REFERENCES AND NOTES
1
FT-IR 8300 spectrophotometer. H NMR and 13C NMR spectra
were recorded in DMSO-d6 and CDCl3 by using a Bruker Avance
DPX instrument (1H NMR 250 MHz, 13C NMR 62.9 MHz).
Chemical shifts were reported in ppm (d) downfield from
TMS. All of the coupling constants (J) are in Hertz. Elemental
analyses were run on a Thermo Finnigan Flash EA-1112
series. Melting points were determined in open capillaries
with a Buchi 510 melting point apparatus. Thin-layer chroma-
tography was carried out on silica gel 254 analytical sheets
obtained from Fluka. Column chromatography was performed
on Merck Kiesel gel (230–270 mesh). Compounds 9c–k were
known, and their spectral data have been previously reported
[6a, 19b,c, 27].
[1] For a review, see: Hansch, C.; Sammes, P. G.; Taylor, J. B.
Comprehensive Medicinal Chemistry; Pergamon Press: Oxford, 1990;
Vol. 2, Chapter 7.1.
[2] (a) Long, T. E.; Turos, E. Curr Med Chem Anti-Infective
Agents 2002, 1, 251; (b) Southgate, R. Contemp Org Synth 1994, 1,
417; (c) Morin, R. B.; Gorman, M. Chemistry and Biology of b-Lactam
Antibiotics; Academic Press: New York, 1982; (d) Georg, G. I. The
Organic Chemistry of b-Lactams; Verlag Chemie: New York, 1993; (e)
J. R. Hwu, S. K. Ethiraj, G. H. Hakimelahi, Mini Rev Med Chem 2003,
3, 305; (f) Meshram, J.; Ali, P.; Tiwari, V. J Het Chem 2010, 47, 1454;
(g) Keri, R. S.; Hosamani, K. M.; Shingalapur, R. V.; Reddy, H. R. S.
Eur J Med Chem 2009, 44, 5123.
[3] Kalir, A.; Kalir, H. H. Biological activity of sulfonic acid
derivatives. In The Chemistry of Sulfonic Acids, Esters and Their
Derivatives; Patai, S.; Rappoport, Z. Eds.; Interscience Publication,
Wiley: Chichester, 1991; 767–787.
[4] Baxter, N. J.; Rigoreau, L. J. M.; Laws, A. P.; Page, M. I. J Am
Chem Soc 2000, 122, 3375.
[5] Baxter, N. J.; Laws, A. P.; Rigoreau, L. J. M.; Page, M. I. J
Chem Soc, Perkin Trans 2 1996, 2245.
[6] (a) Iwama, T.; Kataoka, T.; Muraoka, O.; Tanabe, G. Tetrahedron
1998, 54, 5507; (b) Koller, W.; Linkies, A.; Rehling, H.; Reuschling,
D. Tetrahedron Lett 1983, 24, 2131.
[7] Iwama, T.; Kataoka, T.; Muraoka, O.; Tanabe, G. J Org Chem
1998, 63, 8355.
General procedure. The Vilsmeier reagent ((Chloromethylene)-
dimethylammonium chloride) (1.5 mmol) was added to a solution
of sulfonic acids (1.5mmol), imines (1mmol), and triethylamine
(5.0 mmol) in dry CH2Cl2 (20 mL) at 0ꢁC, and the mixture was
stirred overnight at room temperature. The reaction mixture was
washed successively with saturated NaHCO3 (20 mL) and brine
(20mL). The organic layer was dried (Na2SO4) and filtered, and
the solvent was removed to give the crude product, which was
purified by short-column chromatography on silica gel (EtOAc/
hexane 3:7) to give pure b-sultams 9a–k.
[8] (a) Hinchliffe, P. S.; Wood, J. M.; Davis, A. M.; Austin, R. P.;
Beckett, P. R.; Page, M. I. Org Biomol Chem 2003, 1, 67; (b) Page, M. I.
Acc Chem Res 2004, 37, 297; (c) Tsang, W. Y.; Ahmed, N.; Harding,
L. P.; Hemming, K.; Laws, A. P.; Page, M. I. J Am Chem Soc 2005,
127, 8946.
4-Phenyl-2-(p-methoxyphenyl)-3-(p-nitrophenyl)-1,2-thiazetidine-
1,1-dioxide (9a). White solid; mp: 184–186ꢁC. IR (KBr) cmꢀ1
:
1118, 1306 (SO2), 1337, 1515 (NO2); 1H NMR (250 MHz,
CDCl3) d 3.68 (OMe, s, 3H), 4.60 (H-4, d, 1H, J = 8.6 Hz),
[9] Page, M. I.; Hinchliffe, P. S.; Wood, J. M.; Harding, L. P.;
Laws, A. P. Bioorg Med Chem Lett 2003, 13, 4489.
[10] Llinás, A.; Ahmed, N.; Cordaro, M.; Laws, A. P.; Frère, J.-M.;
Delmarcelle, M.; Silvaggi, N. R.; Kelly, J. A.; Page, M. I. Biochemistry
2005, 44, 7738.
Scheme 2
[11] Ward, R. J.; Lallemand, F.; Witte, P.; Crichton, R. R.;
Piette, J.; Tipton, K.; Hemmings, K.; Pitard, A.; Page, M.;
Della Corte, L.; Taylor, D.; Dexter, D. Biochem Pharmacol 2011,
81, 743.
[12] (a) Iwama, T.; Ogawa, M.; Kataoka, T.; Muraoka, O.; Tanabe,
G. Tetrahedron 1998, 54, 8941; (b) Grunder, E.; Leclerc, G. Synthesis
1989, 135; (c) Enders, D.; Moll, A. Synthesis 2005, 1807.
[13] (a) Zajac, M.; Peters, R. Chem Eur J 2009, 15, 8204; (b) For
review: Iwama, T.; Kataoka, T. Rev Bras Mandioca Rev Heteroatom
Chem 1996, 15, 25.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet